CNBX Pharmaceuticals's total assets for Q1 2025 were $22.31K, a decrease of -28.92% from the previous quarter. CNBX total liabilities were $2.54M for the fiscal quarter, a 1.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.